BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang LY, Zheng SS. Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantation. J Zhejiang Univ Sci B 2018;19:497-504. [PMID: 29971988 DOI: 10.1631/jzus.B1700156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Tian M, Wang B, Xue Z, Dong D, Liu X, Wu R, Yu L, Xiang J, Zhang X, Zhang X, Lv Y. Telemedicine for Follow-up Management of Patients After Liver Transplantation: Cohort Study. JMIR Med Inform 2021;9:e27175. [PMID: 33999008 DOI: 10.2196/27175] [Reference Citation Analysis]
2 Bai YH, Yun XJ, Xue Y, Zhou T, Sun X, Gao YJ. A novel oncolytic adenovirus inhibits hepatocellular carcinoma growth.J Zhejiang Univ Sci B. 2019;20:1003-1013. [PMID: 31749347 DOI: 10.1631/jzus.B1900089] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Dai Y, Shen JL, Zheng XY, Lin TY, Yu HT. Integrated analysis of hypoxia-induced miR-210 signature as a potential prognostic biomarker of hepatocellular carcinoma: a study based on The Cancer Genome Atlas. J Zhejiang Univ Sci B 2019;20:928-32. [PMID: 31595729 DOI: 10.1631/jzus.B1900343] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]